Dr. Xiao Zhao, MD

Dr. Zhao practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Zhao's NPI, 1336585215, was assigned on May 17, 2013. Dr. Zhao graduated from UC San Diego School of Medicine in 2013. Dr. Zhao holds California license 132507.

Dr. Zhao's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Zhao's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Zhao to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhao practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Zhao's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Zhao is board certified in radiation oncology by the American Board of Radiology. Dr. Zhao is licensed in California.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cervical cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Zhao treats.

CMS data shows 2,715 Medicare services from Dr. Zhao across 18 procedure codes in 2024, for 283 Medicare patients. Medicare paid $187,075 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 283 Medicare patients who saw Dr. Zhao in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have cancer, and 70% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhao's median patient age at 66, with 74% women.

In 2024, Dr. Zhao wrote 57 Medicare Part D claims for 26 patients. 91% of them were for generic drugs. CMS names the drug for 23 of them, across 1 drug with 11 or more claims each, at $391 in total drug cost. In 2022, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Zhao for performance year 2024, reported as part of a group. Dr. Zhao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhao as offering telehealth.

Dmand AI links 46 papers to Dr. Zhao, published from 2010 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms, Anthropometry and Cell Line, Tumor. Dr. Zhao has published most often in Nat Commun. Dr. Zhao's most frequent co-authors are Richard K. Valicenti, MD, Scott Victor Bratman, MD, PhD and Rebecca Ann Brooks, MD.

Dmand AI links Dr. Zhao to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Uterine Cervical Neoplasms and Uterine Cervical Diseases.

Dr. Zhao graduated from UC San Diego School of Medicine in 2013.

Dr. Zhao is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.